Financials
- Market Capitalization 1.81 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.15
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2057 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.04 USD | -1.95% | -22.57% | -11.71% | -4.96% | 1.82 B USD | ||
| 2059 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.61 USD | -1.95% | -12.86% | +11.67% | -3.77% | 1.86 B USD | ||
| 2075 | ZYME Zymeworks Inc. - Common Stock | 24.67 USD | +0.04% | -7.43% | +5.88% | +39.06% | 1.80 B USD | ||
| 2088 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.31 USD | -0.90% | -11.02% | +1.22% | -37.43% | 1.75 B USD |